Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)

The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clini...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Lubov I. Petrova [verfasserIn] Snezhana S. Sleptsova [verfasserIn] Maksim N. Andreev [verfasserIn] Nikolai M. Gogolev [verfasserIn] Anastasia N. Petrova [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2018

Schlagwörter:	chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus

Übergeordnetes Werk:	In: International Journal of Biomedicine - International Medical Research and Development Corporation, 2013, 8(2018), 3, Seite 217-219
Übergeordnetes Werk:	volume:8 ; year:2018 ; number:3 ; pages:217-219

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.21103/Article8(3)_OA9

Katalog-ID:	DOAJ001229656

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ001229656
003	DE-627
005	20230309162104.0
007	cr uuu---uuuuu
008	230225s2018 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.21103/Article8(3)_OA9 \|2 doi
035			\|a (DE-627)DOAJ001229656
035			\|a (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	0		\|a Lubov I. Petrova \|e verfasserin \|4 aut
245	1	0	\|a Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
264		1	\|c 2018
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.
650		4	\|a chronic mixed hepatitis
650		4	\|a hepatitis B virus
650		4	\|a hepatitis C virus
650		4	\|a hepatitis D virus
653		0	\|a Medicine
653		0	\|a R
700	0		\|a Snezhana S. Sleptsova \|e verfasserin \|4 aut
700	0		\|a Maksim N. Andreev \|e verfasserin \|4 aut
700	0		\|a Nikolai M. Gogolev \|e verfasserin \|4 aut
700	0		\|a Anastasia N. Petrova \|e verfasserin \|4 aut
773	0	8	\|i In \|t International Journal of Biomedicine \|d International Medical Research and Development Corporation, 2013 \|g 8(2018), 3, Seite 217-219 \|w (DE-627)741171996 \|w (DE-600)2710779-6 \|x 21580529 \|7 nnns
773	1	8	\|g volume:8 \|g year:2018 \|g number:3 \|g pages:217-219
856	4	0	\|u https://doi.org/10.21103/Article8(3)_OA9 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a \|z kostenfrei
856	4	0	\|u http://ijbm.org/articles/IJBM_8(3)_OA9.pdf \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2158-0510 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2158-0529 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 8 \|j 2018 \|e 3 \|h 217-219

Indexfelder

author_variant	l i p lip s s s sss m n a mna n m g nmg a n p anp
matchkey_str	article:21580529:2018----::hoitilifciniheaiibadvrssnhr
hierarchy_sort_str	2018
publishDate	2018
allfields	10.21103/Article8(3)_OA9 doi (DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a DE-627 ger DE-627 rakwb eng Lubov I. Petrova verfasserin aut Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis. chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R Snezhana S. Sleptsova verfasserin aut Maksim N. Andreev verfasserin aut Nikolai M. Gogolev verfasserin aut Anastasia N. Petrova verfasserin aut In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 8(2018), 3, Seite 217-219 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:8 year:2018 number:3 pages:217-219 https://doi.org/10.21103/Article8(3)_OA9 kostenfrei https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a kostenfrei http://ijbm.org/articles/IJBM_8(3)_OA9.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 8 2018 3 217-219
spelling	10.21103/Article8(3)_OA9 doi (DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a DE-627 ger DE-627 rakwb eng Lubov I. Petrova verfasserin aut Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis. chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R Snezhana S. Sleptsova verfasserin aut Maksim N. Andreev verfasserin aut Nikolai M. Gogolev verfasserin aut Anastasia N. Petrova verfasserin aut In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 8(2018), 3, Seite 217-219 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:8 year:2018 number:3 pages:217-219 https://doi.org/10.21103/Article8(3)_OA9 kostenfrei https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a kostenfrei http://ijbm.org/articles/IJBM_8(3)_OA9.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 8 2018 3 217-219
allfields_unstemmed	10.21103/Article8(3)_OA9 doi (DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a DE-627 ger DE-627 rakwb eng Lubov I. Petrova verfasserin aut Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis. chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R Snezhana S. Sleptsova verfasserin aut Maksim N. Andreev verfasserin aut Nikolai M. Gogolev verfasserin aut Anastasia N. Petrova verfasserin aut In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 8(2018), 3, Seite 217-219 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:8 year:2018 number:3 pages:217-219 https://doi.org/10.21103/Article8(3)_OA9 kostenfrei https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a kostenfrei http://ijbm.org/articles/IJBM_8(3)_OA9.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 8 2018 3 217-219
allfieldsGer	10.21103/Article8(3)_OA9 doi (DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a DE-627 ger DE-627 rakwb eng Lubov I. Petrova verfasserin aut Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis. chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R Snezhana S. Sleptsova verfasserin aut Maksim N. Andreev verfasserin aut Nikolai M. Gogolev verfasserin aut Anastasia N. Petrova verfasserin aut In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 8(2018), 3, Seite 217-219 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:8 year:2018 number:3 pages:217-219 https://doi.org/10.21103/Article8(3)_OA9 kostenfrei https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a kostenfrei http://ijbm.org/articles/IJBM_8(3)_OA9.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 8 2018 3 217-219
allfieldsSound	10.21103/Article8(3)_OA9 doi (DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a DE-627 ger DE-627 rakwb eng Lubov I. Petrova verfasserin aut Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis. chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R Snezhana S. Sleptsova verfasserin aut Maksim N. Andreev verfasserin aut Nikolai M. Gogolev verfasserin aut Anastasia N. Petrova verfasserin aut In International Journal of Biomedicine International Medical Research and Development Corporation, 2013 8(2018), 3, Seite 217-219 (DE-627)741171996 (DE-600)2710779-6 21580529 nnns volume:8 year:2018 number:3 pages:217-219 https://doi.org/10.21103/Article8(3)_OA9 kostenfrei https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a kostenfrei http://ijbm.org/articles/IJBM_8(3)_OA9.pdf kostenfrei https://doaj.org/toc/2158-0510 Journal toc kostenfrei https://doaj.org/toc/2158-0529 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 8 2018 3 217-219
language	English
source	In International Journal of Biomedicine 8(2018), 3, Seite 217-219 volume:8 year:2018 number:3 pages:217-219
sourceStr	In International Journal of Biomedicine 8(2018), 3, Seite 217-219 volume:8 year:2018 number:3 pages:217-219
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus Medicine R
isfreeaccess_bool	true
container_title	International Journal of Biomedicine
authorswithroles_txt_mv	Lubov I. Petrova @@aut@@ Snezhana S. Sleptsova @@aut@@ Maksim N. Andreev @@aut@@ Nikolai M. Gogolev @@aut@@ Anastasia N. Petrova @@aut@@
publishDateDaySort_date	2018-01-01T00:00:00Z
hierarchy_top_id	741171996
id	DOAJ001229656
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ001229656</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309162104.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21103/Article8(3)_OA9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ001229656</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Lubov I. Petrova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic mixed hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis B virus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis C virus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis D virus</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Snezhana S. Sleptsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maksim N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nikolai M. Gogolev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anastasia N. Petrova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Biomedicine</subfield><subfield code="d">International Medical Research and Development Corporation, 2013</subfield><subfield code="g">8(2018), 3, Seite 217-219</subfield><subfield code="w">(DE-627)741171996</subfield><subfield code="w">(DE-600)2710779-6</subfield><subfield code="x">21580529</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:217-219</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21103/Article8(3)_OA9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ijbm.org/articles/IJBM_8(3)_OA9.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0510</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0529</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2018</subfield><subfield code="e">3</subfield><subfield code="h">217-219</subfield></datafield></record></collection>
author	Lubov I. Petrova
spellingShingle	Lubov I. Petrova misc chronic mixed hepatitis misc hepatitis B virus misc hepatitis C virus misc hepatitis D virus misc Medicine misc R Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
authorStr	Lubov I. Petrova
ppnlink_with_tag_str_mv	@@773@@(DE-627)741171996
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut
collection	DOAJ
remote_str	true
illustrated	Not Illustrated
issn	21580529
topic_title	Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia) chronic mixed hepatitis hepatitis B virus hepatitis C virus hepatitis D virus
topic	misc chronic mixed hepatitis misc hepatitis B virus misc hepatitis C virus misc hepatitis D virus misc Medicine misc R
topic_unstemmed	misc chronic mixed hepatitis misc hepatitis B virus misc hepatitis C virus misc hepatitis D virus misc Medicine misc R
topic_browse	misc chronic mixed hepatitis misc hepatitis B virus misc hepatitis C virus misc hepatitis D virus misc Medicine misc R
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	International Journal of Biomedicine
hierarchy_parent_id	741171996
hierarchy_top_title	International Journal of Biomedicine
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)741171996 (DE-600)2710779-6
title	Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
ctrlnum	(DE-627)DOAJ001229656 (DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a
title_full	Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
author_sort	Lubov I. Petrova
journal	International Journal of Biomedicine
journalStr	International Journal of Biomedicine
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2018
contenttype_str_mv	txt
container_start_page	217
author_browse	Lubov I. Petrova Snezhana S. Sleptsova Maksim N. Andreev Nikolai M. Gogolev Anastasia N. Petrova
container_volume	8
format_se	Elektronische Aufsätze
author-letter	Lubov I. Petrova
doi_str_mv	10.21103/Article8(3)_OA9
author2-role	verfasserin
title_sort	chronic triple infection with hepatitis b, c, and d viruses in the republic of sakha (yakutia)
title_auth	Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
abstract	The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.
abstractGer	The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.
abstract_unstemmed	The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	3
title_short	Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)
url	https://doi.org/10.21103/Article8(3)_OA9 https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a http://ijbm.org/articles/IJBM_8(3)_OA9.pdf https://doaj.org/toc/2158-0510 https://doaj.org/toc/2158-0529
remote_bool	true
author2	Snezhana S. Sleptsova Maksim N. Andreev Nikolai M. Gogolev Anastasia N. Petrova
author2Str	Snezhana S. Sleptsova Maksim N. Andreev Nikolai M. Gogolev Anastasia N. Petrova
ppnlink	741171996
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.21103/Article8(3)_OA9
up_date	2024-07-03T19:10:57.168Z
_version_	1803586221813792768
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ001229656</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309162104.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2018 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21103/Article8(3)_OA9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ001229656</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ57fec4d1b8e34e329ee514c55240e48a</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Lubov I. Petrova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The purpose of this work was to study the features of the clinical course of mixed infections with hepatitis B+C+D viruses in the Republic of Sakha (Yakutia) (RS(Y)). Materials and Methods: The incidences of these infections were studied in the infectious disease department of the Yakutsk City Clinical Hospital. A total of 74 patients with chronic infection with hepatitis B, C, and D viruses were analyzed. The following markers of HBV (HBsAg, HBeAg, anti-HBcIgG, HBV DNA), HCV (anti-HCV) and HDV (anti-HDV, HDV RNA) were detected. According to PCR (n=35), HCV-RNA was detected in 29(82.8%) patients. In 65.8% of cases, HCV-RNA replication was observed in the absence of HDV-DNA. Mono-replication of HBV (HBV-DNA+, HCV-RNA-) was detected in 17.1% patients, mono-replication of HCV (HBV-DNA-, HCV-RNA+) in 65.7% patients and mixed replication of viruses C, D and/or G (HBV-DNA-, HCV-RNA+, HDV-RNA+/HGV-RNA+) in 17.1% patients. Results: The comparison of biochemical parameters of patients with chronic mixed hepatitis showed that more expressed changes are observed with the mixed replication than with the mono-replicative form of hepatitis.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chronic mixed hepatitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis B virus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis C virus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">hepatitis D virus</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Snezhana S. Sleptsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Maksim N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nikolai M. Gogolev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Anastasia N. Petrova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International Journal of Biomedicine</subfield><subfield code="d">International Medical Research and Development Corporation, 2013</subfield><subfield code="g">8(2018), 3, Seite 217-219</subfield><subfield code="w">(DE-627)741171996</subfield><subfield code="w">(DE-600)2710779-6</subfield><subfield code="x">21580529</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:217-219</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21103/Article8(3)_OA9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/57fec4d1b8e34e329ee514c55240e48a</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ijbm.org/articles/IJBM_8(3)_OA9.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0510</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2158-0529</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2018</subfield><subfield code="e">3</subfield><subfield code="h">217-219</subfield></datafield></record></collection>
score	7.4010477

Nicht das Richtige dabei?

Schreiben Sie uns!

Chronic Triple Infection with Hepatitis B, C, and D Viruses in the Republic of Sakha (Yakutia)

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?